Kazaoka Akira, Kumagai Kazuyoshi, Matsushita Junya, Aida Tetsuo, Kuwahara Saki, Aoki Shigeki, Ito Kousei
Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-City, Chiba 260-8675 Japan.
Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd, Tokyo, Japan.
Toxicol Res. 2024 Jan 6;40(2):223-235. doi: 10.1007/s43188-023-00220-1. eCollection 2024 Apr.
Several patients with cutaneous adverse drug reactions exhibit extracutaneous organ damages, and it becomes severe in a few patients resulting in death due to multiorgan failure. Understanding the sequential changes in various organs in patients with cutaneous eruption following drug administration will help understand disease onset and progression, aiding the development of prevention strategies and interventions. Therefore, we aimed to understand the effects of abacavir (ABC) on various organs in patients with ABC-induced eruptions by evaluating its effects in a mouse model. We found pathological changes in various organs of HLA-B57:01 transgenic mice (B57:01-Tg) following oral administration of ABC (20 mg/body/day). B57:01-Tg exhibited a significant body weight decrease from day 1 of ABC administration, and reddening of the auricle was observed from day 5, and approximately 2/3 mice died by day 7. Histopathological examination revealed severe thymic atrophy after day 3, infiltration of inflammatory cells, predominantly lymphocytes with neutrophils, not only in the skin but also in the liver, kidney, and lung after day 5, and an increased number of lymphocytes with enlarged nuclei and granulocytic hematopoiesis were observed in the spleen after day 5. Blood chemistry revealed that albumin/globulin ratio was below 1.0 on day 5, reflecting a systemic inflammatory response, and the aspartate aminotransferase concentration rose to 193 ± 93.0 U/L on day 7, suggesting that cell damage may have occurred in various organs including liver accompanying inflammatory cell infiltration. These examinations of a mouse model of ABC-induced skin eruption show that disorders in various organs other than the skin should be considered and provide insights into the unexpected early systemic responses dependent on HLA-B57:01.
The online version contains supplementary material available at 10.1007/s43188-023-00220-1.
数例皮肤药物不良反应患者存在皮肤外器官损害,少数患者病情加重,因多器官功能衰竭而死亡。了解药物给药后出现皮疹的患者各器官的序贯变化,将有助于理解疾病的发生和进展,有助于制定预防策略和干预措施。因此,我们旨在通过评估阿巴卡韦(ABC)在小鼠模型中的作用,了解其对ABC诱导皮疹患者各器官的影响。我们发现,口服ABC(20mg/体/天)后,HLA - B57:01转基因小鼠(B57:01 - Tg)的多个器官出现病理变化。从ABC给药第1天起,B57:01 - Tg体重显著下降,第5天观察到耳廓发红,到第7天约2/3的小鼠死亡。组织病理学检查显示,第3天后胸腺严重萎缩,第5天后不仅在皮肤,而且在肝脏、肾脏和肺中均有炎症细胞浸润,以淋巴细胞为主,伴有中性粒细胞,第5天后脾脏中淋巴细胞数量增加,细胞核增大,出现粒细胞造血。血液生化检查显示,第5天白蛋白/球蛋白比值低于1.0,反映全身炎症反应,第7天天冬氨酸转氨酶浓度升至193±93.0U/L,提示包括肝脏在内的多个器官可能伴随炎症细胞浸润发生细胞损伤。这些对ABC诱导皮肤皮疹小鼠模型的检查表明,应考虑皮肤以外的其他器官的紊乱,并为依赖HLA - B57:01的意外早期全身反应提供见解。
在线版本包含可在10.1007/s43188 - 023 - 00220 - 1获取的补充材料。